Frontiers in Endocrinology · Nov 17, 2026
Associations of the TyHGB Index With Coronary Anatomical Burden and Incident Cardiometabolic Multimorbidity: Evidence From Three Chinese Cohorts
By Luzhao Wang, Tao Ding, Zijie Li et al.
Integrated metabolic dysfunction may contribute both to coronary atherosclerotic burden and to the progressive accumulation of cardiometabolic diseases, but a simple marker capturing these processes across clinical and population settings remains unclear. We evaluated the triglyceride/high-density lipoprotein cholesterol–glucose– body mass index (TyHGB) index in three complementary cohorts: 5,128 patients undergoing coronary angiography, 3,251 participants from the China Health and Nutrition Survey, and 6,764 participants from the China Health and Retirement Longitudinal Study. Higher TyHGB was independently associated with angiographic coronary artery disease (odds ratio [OR] per standard deviation [SD], 2.15; 95% confidence interval [CI], 1.98–2.33) and high coronary anatomical burden (SYNTAX score ≥23; OR per SD, 1.54; 95% CI, 1.43–1.67). In pooled population-based analyses, each SD increase in TyHGB was associated with incident cardiometabolic multimorbidity (hazard ratio, 1.17; 95% CI, 1.11–1.22), while the highest versus lowest quartile had a hazard ratio of 1.78 (95% CI, 1.55–2.05). A separate two-stage meta-analysis revealed substantial between-cohort heterogeneity (I² = 85.4% for per-SD and 78.8% for Q4 versus Q1 associations). Increasing or persistently high TyHGB phenotypes were associated with greater subsequent CMM risk than persistently low TyHGB. These findings suggest that TyHGB is associated with coronary anatomical burden and longitudinal cardiometabolic disease progression in distinct clinical and population-based cohorts, providing complementary evidence of its potential relevance to cardiometabolic risk assessment.